AstraNova BioLabs announces the expansion of its phenotypic oncology platform with a validated library of 48 patient-derived tumor organoid lines representing 12 cancer indications, enabling translational research with unprecedented relevance to clinical biology.
Read ArticleResearchers from AstraNova's molecular pharmacology group and collaborating academic partners publish a validated platform for high-throughput PROTAC degradation kinetics and ternary complex assessment in Nature Chemical Biology.
Read ArticleIf an article maps to your program challenge, our scientists can help translate it into assays, controls, and milestone-ready readouts.
Bring us the program question, constraints, and next decision point. We will map the right assays, controls, timeline, and reporting package before the first plate is run.
